Phone Map-marker-alt Facebook X-twitter Instagram Linkedin

Riley Farley

Improve Your Study Pipeline: Essential Performance Metrics for Clinical Research Sites

by
Improve Your Study Pipeline: Essential Performance Metrics for Clinical Research Sites

A clinical research site’s study pipeline is tied to its overall performance, with CROs and sponsors rewarding sites that demonstrate efficiency, reliability, experience, and strong patient recruitment capabilities with more trial opportunities. Maintaining a strong and efficient study pipeline is critical for the success of any site. Having a well-managed pipeline ensures a steady flow … Read more

eSource vs. Traditional Paper-Based Methods in Clinical Trials 

by

The evolution of data collection and management in clinical trials has seen a significant shift from traditional paper-based methods to electronic source (eSource). This transition has brought about profound changes in how clinical trials are conducted, driving increased data precision and staff efficiency, and the overall management of clinical trial data. Here, we dissect the … Read more

Site Spotlight: EmVenio Research – How EmVenio is Leveraging Technology to Increase Diversity in Clinical Trials

by
Site Spotlight EmVenio Research

An interview with Phillip Stanford, Senior Director, Applications & PMO at EmVenio Research, a PCM Trials Company. Q: Can you tell us more about EmVenio Research’s business model and how it’s expanding research to underrepresented communities? A: EmVenio Research provides a scalable network of clinical trial sites. We are strategically located in clinical trial naïve … Read more

Standardizing Pipeline Management and Study Start-up in Clinical Trials 

by

As clinical research organizations grow, many tasks can become siloed and the overall lack of transparency can lead to inefficiencies, delays, and increased costs. Standardizing study start-up and pipeline management is crucial for improving trial efficiency, ensuring regulatory compliance, and enhancing data quality. By implementing a centralized platform and establishing standardized operations across all site … Read more

RealTime eClinical Solutions Chosen by a Top 5 Global CRO for Industry-leading eClinical Solutions  

by

This press release was initially published on Cision/PR Newswire. You can view the original release here. SAN ANTONIO, Texas, (July 16, 2024) – RealTime eClinical Solutions, a leading provider of innovative clinical trial management technology, is proud to announce its selection by one of the leading, top five global Contract Research Organizations (CROs) as a … Read more

Top 5 Challenges in Clinical Trial Study Start-up and Pipeline Management 

by
Top 5 Challenges in Clinical Trial Study Start-Up and Pipeline Management

Study start-up and pipeline management are fraught with challenges that can hinder progress and efficiency. These complex processes involve meticulous planning, coordination, and execution from all parts of a research site organization, leaving ample opportunity for delays. Despite advances in technology and methodologies, research teams continue to face significant challenges that can extend timelines and … Read more

How RealTime-Devana Aided Helios Clinical Research’s Rapid Growth

by

Helios is a rapidly growing organization aiming to regularly add and onboard new sites. Unfortunately, their method for feasibility and other key processes have historically been site-based and lacked a cohesive, centralized plan. Additionally, their trial pipeline was highly individualized making it difficult for leadership to analyze, obscuring any potential trends and making processes hard to scale.

How RealTime-Devana Helped MUSC Gain Performance Transparency to Improve Therapeutic Alignment

by

MUSC had hundreds of study opportunities to consider for feasibility to determine which were a therapeutic fit based on physician investigator and staff experience and availability, but their Feasibility Analysis Team lacked transparency into historic and currently running clinical trials to gauge past trial success and current investigator bandwidth.